Maria (Masha) Babak: The potential of metal-based compounds to ICD in cancer cells
Maria (Masha) Babak, Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong, reshared a post by The Babak Lab on LinkedIn:
“Thrilled to share our latest review in Chemical Science exploring the potential of metal-based compounds to induce immunogenic cell death (ICD) in cancer cells!”
Quoting The Babak Lab‘s post:
“Exciting News!
We are thrilled to announce the publication of our latest review article in Chemical Science titled ‘Metal-Based Immunogenic Cell Death Inducers for Cancer Immunotherapy’.
In this comprehensive review, we explore:
- The world of metal-based compounds and their potential to induce immunogenic cell death (ICD) in cancer cells.
- ICD as a unique form of cell death that not only eradicates cancer cells but also activates the immune system to mount a robust anti-tumor response.
Our article provides:
- In-depth exploration of the molecular mechanisms behind ICD.
- Current landscape of metal-based ICD inducers.
- Applications of metal-based ICD inducers in cancer immunotherapy.
Read the full article here.
A huge thank you to all the co-authors and collaborators for their invaluable contributions!”
Metal-based immunogenic cell death inducers for cancer immunotherapy.
Authors: Jiao Xia Zou, et al.
More posts featuring Maria (Masha) Babak.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023